Skip to main content
Advertising

Originally published Wednesday, June 11, 2014 at 4:00 PM

  • Share:
           
  • Comments (0)
  • Print

Kineta, Children’s join in pediatric clinical-trial effort

The Seattle biotechnology company Kineta and Seattle Children’s Research Institute are joining in an effort to improve development and testing of therapies for pediatric autoimmune diseases.


By Seattle Times staff

advertising

Seattle biotechnology company Kineta and Seattle Children’s Research Institute are joining in an effort to improve development and testing of therapies for pediatric autoimmune diseases.

Their collaboration, called Alliance for Children’s Therapeutics, will be funded both by philanthropic gifts to the research institute and equity investments in Kineta. Its initial aim is to raise $1.5 million and conduct clinical trials of a Kineta drug in treating childhood-onset lupus nephritis, a spokesman said.

Researchers say clinical trials of new drugs typically don’t include children, creating uncertainty about the effects and dosages.



Want unlimited access to seattletimes.com? Subscribe now!

Also in Business & Technology

News where, when and how you want it

Email Icon

Where in the world are Seahawks fans?

Where in the world are Seahawks fans?

Put your marker on The Seattle Times interactive map and share your fan story.

Advertising

Advertising


Advertising
The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Subscriber login ►
The Seattle Times

To keep reading, you need a subscription upgrade.

We hope you have enjoyed your complimentary access. For unlimited seattletimes.com access, please upgrade your digital subscription.

Call customer service at 1.800.542.0820 for assistance with your upgrade or questions about your subscriber status.

The Seattle Times

To keep reading, you need a subscription.

We hope you have enjoyed your complimentary access. Subscribe now for unlimited access!

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Activate Subscriber Account ►